However, there was no difference in PON1 protein levels, or in paraoxonase, arylesterase or diazoxonase activities, and the rates of organophosphate hydrolysis had no effect on the survival of patients with ALS. The gene discussed is PON1; the disease is amyotrophic lateral sclerosis.